DEF: Nuvve Holding Corp. Seeks Stockholder Approval for Share Issuance and Increased Authorized Shares

Nuvve Holding Corp. is holding a special meeting to seek stockholder approval for issuing shares related to convertible notes and warrants, and to increase the number of authorized shares.

Summary

• Nuvve Holding Corp. is requesting stockholder approval for several key proposals at a special meeting on February 21, 2025.
• The first proposal seeks approval for the issuance of common stock related to senior secured convertible notes and warrants, exceeding a previously set 19.99% share cap.
• This includes shares issued to an executive officer as part of the same agreement.
• The second proposal aims to amend the company's charter to increase the total authorized common stock from 100 million to 200 million shares.
• The third proposal requests authorization to adjourn the special meeting if necessary to gather additional proxies.
• The company entered into a Securities Purchase Agreement on October 31, 2024, issuing convertible notes and warrants to investors.
• These notes are convertible at $3.402 per share, subject to adjustments, and the warrants have an exercise price of $3.78 per share.
• The company is seeking approval to issue more than 20% of its outstanding shares due to the terms of the agreement and anti-dilution provisions.
• The company intends to use the proceeds from the private placement for working capital and general corporate purposes.

Sentiment

Score: 4

Explanation: The document indicates a need for significant capital raising and potential dilution, which is generally viewed negatively by investors. While the company is taking steps to secure funding, the terms of the financing and the potential for dilution are concerning.

Positives

• The company is seeking to raise additional capital through the issuance of convertible notes and warrants.
• The increase in authorized shares provides flexibility for future strategic, business, and financial purposes.
• The company has secured a private placement of $3,375,000.01.
• The company has an additional investment right for up to $12,500,000.
• The company has filed and had a resale registration statement declared effective by the SEC.

Negatives

• The issuance of additional shares will dilute the ownership of existing stockholders.
• The anti-dilution provisions in the notes and warrants could significantly increase the number of shares issued.
• Failure to obtain stockholder approval for the share issuance could limit the company's ability to raise capital.
• The company may incur additional expenses and management time if the issuance proposal is not approved.
• The company may be required to hold additional stockholder meetings if the issuance proposal is not approved.

Risks

• The company's ability to execute its business plan is dependent on raising additional capital.
• The market price of the company's common stock could decline due to the issuance of new shares.
• The increased number of issued shares could have an anti-takeover effect.
• There is no guarantee that the investors will exercise their warrants.
• The company may be required to curtail its expansion plans if it cannot raise additional capital.

Future Outlook

The company intends to use the net proceeds from the private placement for working capital and general corporate purposes and may raise additional capital through the additional investment right. The company will also seek to register the resale of shares issued under the notes and warrants.

Management Comments

• The Board has determined the proposed amendment and increase of the Common Stock to be advisable and in the best interests of the Company and our stockholders.
• The Board believes it is appropriate to increase our authorized shares of Common Stock so that we have shares of Common Stock available to provide additional flexibility to promptly and appropriately use our Common Stock for strategic, business and financial purposes in the future.

Industry Context

This announcement is typical for companies seeking to raise capital and ensure compliance with listing rules. The need for shareholder approval for significant share issuances is a common requirement for companies listed on the Nasdaq.

Comparison to Industry Standards

• The use of convertible notes and warrants is a common method for raising capital, particularly for growth-stage companies.
• The anti-dilution provisions are standard in such agreements to protect investors from significant price drops.
• The requirement for shareholder approval for issuances exceeding 20% is consistent with Nasdaq listing rules.
• The proposed increase in authorized shares is a common practice to provide flexibility for future financing and strategic opportunities.
• Comparable companies in the technology and electric vehicle sectors often use similar financing methods.

Related Party Transactions

• Gregory Poilasne, the company's CEO, participated in the private placement, purchasing $250,000 in notes and warrants.

Stakeholder Impact

• Existing shareholders will experience dilution of their ownership if the share issuance is approved.
• The company's ability to raise capital will impact its ability to execute its business plan, affecting employees and other stakeholders.
• The company's financial stability and future growth will be influenced by the outcome of the proposals.

Next Steps

• Stockholders will vote on the proposals at the Special Meeting on February 21, 2025.
• The company will file a Certificate of Amendment with the Secretary of State of Delaware if the authorized shares proposal is approved.
• The company will continue to seek additional capital to fund its operations and expansion plans.

Key Dates

Keywords

stockholder approval, common stock, convertible notes, warrants, share issuance, authorized shares, private placement, dilution, Nasdaq Listing Rules, capital raise